Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Thyroid Diseases 1Parathyroid Diseases 1Neurilemmoma 1Neoplasms 1Meningioma 1Lung Neoplasms 1Low Grade Glioma of Brain 1Liver Neoplasms 1Inflammatory Bowel Diseases 1Inflammation 1Glioma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 109Magnetic Resonance Spectroscopy 52Bevacizumab 52Radiotherapy 44Irinotecan 27Blood Specimen Collection 19Surgical Procedures, Operative 16Radiation 15Aminolevulinic Acid 15Carboplatin 13fluorodopa F 18 12Nivolumab 12Radiotherapy, Intensity-Modulated 11Carmustine 11Radiosurgery 10Magnetic Resonance Imaging 10pembrolizumab 9Topotecan 9Specimen Handling 9Everolimus 9Erlotinib Hydrochloride 9Biopsy 9poly ICLC 8Surveys and Questionnaires 8Standard of Care 8Etoposide 8Drug Therapy 8Lomustine 7Filgrastim 7Cyclophosphamide 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Glioma × Hyperspectral Imaging × Clear all
NCT04712214 2023-04-25

Use of Non-invasive Optical Analysis in Neurosurgery

Imperial College London

Phase NA Unknown
50 enrolled
CNS

Brain Neoplasms, Glioma, Meningioma, Neurilemmoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡